wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36610517-4DD18F36-7BB6-4929-9845-28FF4D14D51E
Q36610517-4DD18F36-7BB6-4929-9845-28FF4D14D51E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36610517-4DD18F36-7BB6-4929-9845-28FF4D14D51E
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
P698
Q36610517-4DD18F36-7BB6-4929-9845-28FF4D14D51E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36610517-4DD18F36-7BB6-4929-9845-28FF4D14D51E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7345ffb9ad67a378d707dcf075e9db278137206
P698
17179992
http://www.w3.org/2001/XMLSchema#string